All positive (IHC 3+) and doubtful (IHC 2+) cases were ... (LVEF), and resistant relapse after first- or second-line paclitaxel/carboplatin chemotherapy received paclitaxel (175 mg/m 2 for 3 ...
Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer. J. Clin. Oncol. 26, 5544–5552 (2008).
Isabelle Ray-Coquard; Jean Paul Guastalla; Djelila Allouache; Martin Combe; Béatrice Weber; J. Cretin; Hervé Curé; S. Nunhuck; Désiré Paraiso; Mireille Mousseau ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback